Cristiana Campa advances vaccine development through improved specifications and regulatory frameworks, indicating progress in vaccine quality.
Cristiana Campa examines how advances in analytical characterization and risk-based regulatory frameworks are redefining vaccine development and manufacturing. Drawing on her work revising the ICH Q6 guideline on specifications, she discusses the role of harmonized, science-driven standards in supporting vaccine quality, global development pathways, and emerging modalities such as therapeutic and mRNA-based vaccines.
No takes yet. Share an insight, caveat, or question.
Cristiana Campa (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: